Novo Nordisk’s stock tumbles after its oral GLP-1 drug failed to show much benefit over a placebo against Alzheimer’s.
Source: https://www.marketwatch.com/story/novo-nordisks-oral-glp-1-drug-didnt-work-on-alzheimers-as-hoped-and-the-stock-tumbles-76a8d78f?mod=mw_rss_topstories
About the Author
